These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 37026450)
1. The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIα. Griem-Krey N; Klein AB; Clausen BH; Namini MR; Nielsen PV; Bhuiyan M; Nagaraja RY; De Silva TM; Sobey CG; Cheng HC; Orset C; Vivien D; Lambertsen KL; Clarkson AN; Wellendorph P J Cereb Blood Flow Metab; 2023 Aug; 43(8):1419-1434. PubMed ID: 37026450 [TBL] [Abstract][Full Text] [Related]
2. The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction. Griem-Krey N; Gauger SJ; Gowing EK; Thiesen L; Frølund B; Clarkson AN; Wellendorph P Biomed Pharmacother; 2022 Dec; 156():113895. PubMed ID: 36274464 [TBL] [Abstract][Full Text] [Related]
3. GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain. Leurs U; Klein AB; McSpadden ED; Griem-Krey N; Solbak SMØ; Houlton J; Villumsen IS; Vogensen SB; Hamborg L; Gauger SJ; Palmelund LB; Larsen ASG; Shehata MA; Kelstrup CD; Olsen JV; Bach A; Burnie RO; Kerr DS; Gowing EK; Teurlings SMW; Chi CC; Gee CL; Frølund B; Kornum BR; van Woerden GM; Clausen RP; Kuriyan J; Clarkson AN; Wellendorph P Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330837 [TBL] [Abstract][Full Text] [Related]
4. CaMKIIα as a Promising Drug Target for Ischemic Grey Matter. Griem-Krey N; Clarkson AN; Wellendorph P Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552099 [TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1. Thiesen L; Kehler J; Clausen RP; Frølund B; Bundgaard C; Wellendorph P J Pharmacol Exp Ther; 2015 Aug; 354(2):166-74. PubMed ID: 25986445 [TBL] [Abstract][Full Text] [Related]
6. Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain. Wellendorph P; Høg S; Greenwood JR; de Lichtenberg A; Nielsen B; Frølund B; Brehm L; Clausen RP; Bräuner-Osborne H J Pharmacol Exp Ther; 2005 Oct; 315(1):346-51. PubMed ID: 16014570 [TBL] [Abstract][Full Text] [Related]
15. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor. Vest RS; O'Leary H; Coultrap SJ; Kindy MS; Bayer KU J Biol Chem; 2010 Jul; 285(27):20675-82. PubMed ID: 20424167 [TBL] [Abstract][Full Text] [Related]
16. Autophosphorylated calcium/calmodulin-dependent protein kinase II alpha (CaMKII alpha) reversibly targets to and phosphorylates N-methyl-D-aspartate receptor subunit 2B (NR2B) in cerebral ischemia and reperfusion in hippocampus of rats. Meng F; Guo J; Zhang Q; Song B; Zhang G Brain Res; 2003 Mar; 967(1-2):161-9. PubMed ID: 12650977 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide induces Ca2+-independent activity of the Ca2+/calmodulin-dependent protein kinase II (CaMKII). Coultrap SJ; Bayer KU J Biol Chem; 2014 Jul; 289(28):19458-65. PubMed ID: 24855644 [TBL] [Abstract][Full Text] [Related]
18. CaMKII in cerebral ischemia. Coultrap SJ; Vest RS; Ashpole NM; Hudmon A; Bayer KU Acta Pharmacol Sin; 2011 Jul; 32(7):861-72. PubMed ID: 21685929 [TBL] [Abstract][Full Text] [Related]
19. Physiological and Pathological Roles of CaMKII-PP1 Signaling in the Brain. Shioda N; Fukunaga K Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271887 [TBL] [Abstract][Full Text] [Related]
20. Tilianin improves cognition in a vascular dementia rodent model by targeting miR-193b-3p/CaM- and miR-152-3p/CaMKIIα-mediated inflammatory and apoptotic pathways. Sun T; Tan L; Liu M; Zeng L; Zhao K; Cai Z; Sun S; Li Z; Liu R Front Immunol; 2023; 14():1118808. PubMed ID: 37153565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]